NCBI PubMed Central
open access
Design and therapeutic rationale of antibody-peptide conjugates: insights from maridebart cafraglutide (AMG133) and emerging applications.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Fludarabine Phosphate, Rituximab, and Bevacizumab in Treating Patients With B-Cell Chronic Lymphocytic Leukemia That Has Relapsed or Not Responded To Treatment#892240
- Application of the OBIMAP (One-Bead Interchain Multipeptide Assembly Platform) to long peptide synthesis: liraglutide as a case study#295966
- FLT3 inhibitors in AML: from classic scaffolds to next-generation approaches.#378403
- Self-assembling functional programmable protein array for studying protein-protein interactions in malaria parasites#236920
- AK112 Plus Platinum-based Chemotherapy for EGFR/ALK/ROS1 Positve NSCLC#908131
Record · ID 452922
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive